Developments in cancer treatment have been boosted by a new study that identifies the link between a woman's history of abnormal cervical cell growth and the potential for recurrence.
Examining data from a cytology database collated by the British Columbia Cancer Agency, the research showed that the risk of cervical cancer recurring was dependant on a woman's age, the stage at which the cancer had been caught and the type of treatment administered.
The study was led by Joy Melnikow, professor of family and community medicine and associate director of the UC Davis Center for Healthcare Policy and Research.
She commented: "These data may help inform that treatment discussion, because we know more about how age and different treatments appear to influence risks."
A report by the Institute of Cancer Research has indicated that women who have normal cervical cancer smears during their 40s should continue to be tested in their 50s as the cancer can appear later in life.